Systemic Bevacizumab (Avastin) Therapy for Neovascular...

Systemic Bevacizumab (Avastin) Therapy for Neovascular Age-Related Macular Degeneration: Twenty-Four–Week Results of an Uncontrolled Open-Label Clinical Study

Andrew A. Moshfeghi, Philip J. Rosenfeld, Carmen A. Puliafito, Stephan Michels, Erin N. Marcus, Joshua D. Lenchus, Anna S. Venkatraman
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
113
Year:
2006
Language:
english
DOI:
10.1016/j.ophtha.2006.05.070
File:
PDF, 2.84 MB
english, 2006
Conversion to is in progress
Conversion to is failed